Your browser doesn't support javascript.
loading
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth, Dominik A; Sareban, Nazanin; Lindner, Andrea K; Daller, Louisa A J; Matzhold, Eva Maria; Hutterer, Georg; Smolle, Maria; Mischinger, Johannes; Riedl, Jakob M; Seles, Maximilian; Mannweiler, Sebastian; Bauernhofer, Thomas; Pummer, Karl; Pichler, Renate; Zigeuner, Richard; Schlenke, Peter; Pichler, Martin.
Afiliación
  • Barth DA; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Sareban N; Department of Blood Group Serology and Transfusion Medicine, Medical University Graz, Austria.
  • Lindner AK; Department of Urology, Medical University of Innsbruck, Austria.
  • Daller LAJ; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Matzhold EM; Department of Blood Group Serology and Transfusion Medicine, Medical University Graz, Austria.
  • Hutterer G; Department of Urology, Medical University of Graz, Austria.
  • Smolle M; Department of Orthopedics and Trauma, Medical University of Graz, Austria.
  • Mischinger J; Department of Urology, Medical University of Graz, Austria.
  • Riedl JM; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Seles M; Department of Urology, Medical University of Graz, Austria.
  • Mannweiler S; Intitute for Pathology, Medical University of Graz, Austria.
  • Bauernhofer T; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Pummer K; Department of Urology, Medical University of Graz, Austria.
  • Pichler R; Department of Urology, Medical University of Innsbruck, Austria.
  • Zigeuner R; Department of Urology, Medical University of Graz, Austria.
  • Schlenke P; Department of Blood Group Serology and Transfusion Medicine, Medical University Graz, Austria.
  • Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: martin.pichler@medunigraz.at.
Urol Oncol ; 39(10): 736.e9-736.e16, 2021 10.
Article en En | MEDLINE | ID: mdl-34247906
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistema del Grupo Sanguíneo ABO / Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sistema del Grupo Sanguíneo ABO / Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Austria